S. Itoh et H. Shimada, BONE-MARROW AND LIVER MUTAGENESIS IN LACZ TRANSGENIC MICE TREATED WITH HEXAVALENT CHROMIUM, Mutation research. Genetic toxicology and environmental mutagenesis, 412(1), 1998, pp. 63-67
The mutagenic effects of the hexavalent chromium compound K2CrO4 in la
cZ transgenic mice (Muta(TM) Mouse) were investigated at two sampling
times. K2CrO4 was administered intraperitoneally to five male mice per
treatment group at a single dose of 40 mg/kg. The animals were sacrif
iced on days 1 and 7 after the treatment. Mutant frequencies in the bo
ne marrow and liver were analyzed by the positive selection method usi
ng Escherichia coli C (galE(-)) strain and phenyl beta-D-galactoside.
K2CrO4 induced a significant increase in mutant frequency in the bone
marrow on day 1, but not on day 7 after the treatment. In the liver, o
n the other hand, a significant induction in the mutant frequency was
seen on day 7, whereas no induction was observed on day 1. The reason
for the different responses to the mutagenic activity of K2CrO4 betwee
n these organs may be related to their cell turnover rates. The mutati
ons induced by K2CrO4 in the bone marrow may have occurred in more dif
ferentiated cells than stem cells, and the rapid proliferative activit
y may have caused a rapid decrease in mutated cells by day 7, These re
sults suggest that experiments on mutagenesis should be done with more
than one sampling point, a short expression time in addition to a lon
ger one, so as to detect mutations induced in organ with high cell pro
liferation. (C) 1998 Elsevier Science B.V.